10-Q
Quarterly Report
Actuate Therapeutics, Inc.
ACTU
NASDAQ
CIK: 1652935
File #: 001-42139
Balance Sheet
31 line items · 2 periods
XBRL
| Item | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 3,889,405 | 8,641,622 |
Other Non-Operating Current Assets | 359,159 | 566,278 |
Total current assets | 4,248,564 | 9,207,900 |
Other Non-Operating Non-Current Assets | 234,475 | 110,548 |
Total assets | 4,483,039 | 9,318,448 |
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
Current liabilities: | ||
Accounts Payable | 2,644,349 | 1,921,189 |
Other Non-Operating Current Liabilities | 5,200,762 | 5,921,908 |
Other Current Liabilities | 1,237,886 | 888,449 |
Other Non-Operating Current Liabilities | 70,957 | 70,957 |
UIC License Agreement | 70,957 | 70,957 |
Total current liabilities | 9,153,954 | 8,802,503 |
Long term liabilities: | ||
Other Non-Operating Current Liabilities | 11,831 | 6,768 |
UIC License Agreement | 82,788 | 77,725 |
Other Non-Operating Current Liabilities | 404,991 | 404,991 |
Total long-term liabilities | 416,822 | 411,759 |
Total liabilities | 9,570,776 | 9,214,262 |
Stockholders’ equity (deficit): | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 20 | 20 |
Total Stockholders' Equity | 133,609,116 | 132,484,015 |
Total Stockholders' Equity | (138,696,873) | (132,379,849) |
Total stockholders’ equity (deficit) | (5,087,737) | 104,186 |
Common Stock | 20 | 20 |
Additional Paid-in Capital | 133,609,116 | 132,484,015 |
Retained Earnings | (138,696,873) | (132,379,849) |
Total liabilities and stockholders’ equity (deficit) | 4,483,039 | 9,318,448 |